{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:44:20Z","timestamp":1790401460220,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02453-y","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T10:02:17Z","timestamp":1721642537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anticancer effects of Artemisia campestris extract on acute myeloid leukemia cells: an ex vivo study"],"prefix":"10.1007","volume":"41","author":[{"given":"Rachid","family":"Kharrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Ben","family":"Lakhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Souia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Limam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend Ben","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-6083","authenticated-orcid":false,"given":"Mohamed","family":"Abdelkarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"2453_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2026","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n2026.","journal-title":"BMJ"},{"key":"2453_CR2","doi-asserted-by":"publisher","first-page":"101333","DOI":"10.1016\/j.beha.2021.101333","volume":"34","author":"JM Rowe","year":"2021","unstructured":"Rowe JM. Changing trends in the therapy of acute myeloid leukemia. Best Pract Res Clin Haematol. 2021;34: 101333.","journal-title":"Best Pract Res Clin Haematol"},{"key":"2453_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41467-023-43843-6","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Sica RA, Kaur G, Galbo PM, Jing Z, Nishimura CD, et al. TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nat Commun. 2024;15:11.","journal-title":"Nat Commun"},{"key":"2453_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108:353\u201366.","journal-title":"Haematologica"},{"key":"2453_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12032-024-02302-y","volume":"41","author":"IM Bouligny","year":"2024","unstructured":"Bouligny IM, Murray G, Doyel M, Patel T, Boron J, Tran V, et al. Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia. Med Oncol. 2024;41:80.","journal-title":"Med Oncol"},{"key":"2453_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11864-020-00765-5","volume":"21","author":"F Thol","year":"2020","unstructured":"Thol F, Ganser A. Treatment of relapsed acute myeloid leukemia. Curr Treat Options Oncol. 2020;21:66.","journal-title":"Curr Treat Options Oncol"},{"key":"2453_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers16071351","volume":"16","author":"P Bercier","year":"2024","unstructured":"Bercier P, de Th\u00e9 H. History of developing acute promyelocytic leukemia treatment and role of promyelocytic leukemia bodies. Cancers. 2024;16:1351.","journal-title":"Cancers"},{"key":"2453_CR8","doi-asserted-by":"publisher","first-page":"10529","DOI":"10.3390\/ijms231810529","volume":"23","author":"V Weeda","year":"2022","unstructured":"Weeda V, Mestrum SGC, Leers MPG. Flow cytometric identification of hematopoietic and leukemic blast cells for tailored clinical follow-up of acute myeloid leukemia. Int J Mol Sci. 2022;23:10529.","journal-title":"Int J Mol Sci"},{"key":"2453_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4252\/wjsc.v9.i12.227","volume":"9","author":"A Plesa","year":"2017","unstructured":"Plesa A, Dumontet C, Mattei E, Tagoug I, Hayette S, Sujobert P, et al. High frequency of CD34+CD38\u2212\/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia. World J Stem Cells. 2017;9:227\u201334.","journal-title":"World J Stem Cells"},{"key":"2453_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","volume":"19","author":"N Goardon","year":"2011","unstructured":"Goardon N, Marchi E, Atzberger A, Quek L, Schuh A, Soneji S, et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell. 2011;19:138\u201352.","journal-title":"Cancer Cell"},{"key":"2453_CR11","doi-asserted-by":"publisher","first-page":"867684","DOI":"10.3389\/fonc.2022.867684","volume":"12","author":"AM Kamel","year":"2022","unstructured":"Kamel AM, Elsharkawy NM, Kandeel EZ, Hanafi M, Samra M, Osman RA. Leukemia stem cell frequency at diagnosis correlates with measurable\/minimal residual disease and impacts survival in adult acute myeloid leukemia. Front Oncol. 2022;12: 867684.","journal-title":"Front Oncol"},{"key":"2453_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3390\/cancers12051174","volume":"12","author":"F Vergez","year":"2020","unstructured":"Vergez F, Nicolau-Travers M-L, Bertoli S, Rieu J-B, Tavitian S, Bories P, et al. CD34+CD38\u2212CD123+ leukemic stem cell frequency predicts outcome in older acute myeloid leukemia patients treated by intensive chemotherapy but not hypomethylating agents. Cancers. 2020;12:1174.","journal-title":"Cancers"},{"key":"2453_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11912-022-01199-y","volume":"24","author":"P Singh","year":"2022","unstructured":"Singh P, Lim B. Targeting apoptosis in cancer. Curr Oncol Rep. 2022;24:273\u201384.","journal-title":"Curr Oncol Rep"},{"key":"2453_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"key":"2453_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biom13020194","volume":"13","author":"AK Wani","year":"2023","unstructured":"Wani AK, Akhtar N, Mir TUG, Singh R, Jha PK, Mallik SK, et al. Targeting apoptotic pathway of cancer cells with phytochemicals and plant-based nanomaterials. Biomolecules. 2023;13:194.","journal-title":"Biomolecules"},{"key":"2453_CR16","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/molecules26092741","volume":"26","author":"T Maher","year":"2021","unstructured":"Maher T, Ahmad Raus R, Daddiouaissa D, Ahmad F, Adzhar NS, Latif ES, et al. Medicinal plants with anti-leukemic effects: a review. Molecules. 2021;26:2741.","journal-title":"Molecules"},{"key":"2453_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/tox.23090","volume":"36","author":"I Limam","year":"2021","unstructured":"Limam I, Ben Aissa-Fennira F, Essid R, Chahbi A, Kefi S, Mkadmini K, et al. Hydromethanolic root and aerial part extracts from Echium arenarium Guss suppress proliferation and induce apoptosis of multiple myeloma cells through mitochondrial pathway. Environ Toxicol. 2021;36:874\u201386.","journal-title":"Environ Toxicol"},{"key":"2453_CR18","doi-asserted-by":"publisher","first-page":"101145","DOI":"10.1016\/j.eujim.2020.101145","volume":"37","author":"I Limam","year":"2020","unstructured":"Limam I, Abdelkarim M, Essid R, Chahbi A, Fathallah M, Elkahoui S, et al. Olea europaea L. cv. Chetoui leaf and stem hydromethanolic extracts suppress proliferation and promote apoptosis via caspase signaling on human multiple myeloma cells. Eur J Integr Med. 2020;37:101145.","journal-title":"Eur J Integr Med"},{"key":"2453_CR19","first-page":"251","volume":"5","author":"N Hendel","year":"2021","unstructured":"Hendel N, Djamel S, Madani S, Selloum M, Boussakra F, Driche O. Screening for in vitro antioxidant activity and antifungal effect of Artemisia campestris. Int J Agric Environ Food Sci. 2021;5:251\u20139.","journal-title":"Int J Agric Environ Food Sci"},{"key":"2453_CR20","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.biopha.2018.10.149","volume":"109","author":"I Dib","year":"2019","unstructured":"Dib I, El Alaoui-Faris FE. Artemisia campestris L.: review on taxonomical aspects, cytogeography, biological activities and bioactive compounds. Biomed Pharmacother. 2019;109:1884\u2013906.","journal-title":"Biomed Pharmacother"},{"key":"2453_CR21","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1016\/j.bmc.2003.08.008","volume":"11","author":"SH Lee","year":"2003","unstructured":"Lee SH, Lee M-Y, Kang H-M, Han DC, Son K-H, Yang DC, et al. Anti-tumor activity of the farnesyl-protein transferase inhibitors arteminolides, isolated from Artemisa. Bioorg Med Chem. 2003;11:4545\u20139.","journal-title":"Bioorg Med Chem"},{"key":"2453_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hermed.2016.10.005","volume":"7","author":"I Dib","year":"2017","unstructured":"Dib I, Angenot L, Mihamou A, Ziyyat A, Tits M. Artemisia campestris L.: ethnomedicinal, phytochemical and pharmacological review. J Herb Med. 2017;7:1\u201310.","journal-title":"J Herb Med"},{"key":"2453_CR23","first-page":"63","volume":"25","author":"M-A Jabri","year":"2018","unstructured":"Jabri M-A, Tounsi H, Abdellaoui A, Marzouki L, Sebai H. Protective effects of Artemisia campestris extract against gastric acid reflux-induced esophageal mucosa injuries. Pathophysiol Off J Int Soc Pathophysiol. 2018;25:63\u20139.","journal-title":"Pathophysiol Off J Int Soc Pathophysiol"},{"key":"2453_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.fct.2010.11.003","volume":"49","author":"A Akrout","year":"2011","unstructured":"Akrout A, Gonzalez LA, El Jani H, Madrid PC. Antioxidant and antitumor activities of Artemisia campestris and Thymelaea hirsuta from southern Tunisia. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2011;49:342\u20137.","journal-title":"Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc"},{"key":"2453_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.sajb.2022.10.002","volume":"151","author":"R Metoui","year":"2022","unstructured":"Metoui R, Mighri H, Bouajila J, Znati M, El-Jani H, Akrout A. Artemisia campestris dried leaf extracts: effects of different extraction methods and solvents on phenolic composition and biological activities. South Afr J Bot. 2022;151:288\u201394.","journal-title":"South Afr J Bot"},{"key":"2453_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13007-024-01185-4","volume":"20","author":"I Limam","year":"2024","unstructured":"Limam I, Ghali R, Abdelkarim M, Ouni A, Araoud M, Abdelkarim M, et al. Tunisian Artemisia campestris L.: a potential therapeutic agent against myeloma\u2014phytochemical and pharmacological insights. Plant Methods. 2024;20:59.","journal-title":"Plant Methods"},{"key":"2453_CR27","doi-asserted-by":"publisher","first-page":"107650","DOI":"10.1016\/j.pharmthera.2020.107650","volume":"216","author":"X Feng","year":"2020","unstructured":"Feng X, Cao S, Qiu F, Zhang B. Traditional application and modern pharmacological research of Artemisia annua L. Pharmacol Ther. 2020;216: 107650.","journal-title":"Pharmacol Ther"},{"key":"2453_CR28","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.3390\/cancers13153747","volume":"13","author":"O Jaouadi","year":"2021","unstructured":"Jaouadi O, Limam I, Abdelkarim M, Berred E, Chahbi A, Caillot M, et al. 5,6-Epoxycholesterol isomers induce oxiapoptophagy in myeloma cells. Cancers. 2021;13:3747.","journal-title":"Cancers"},{"key":"2453_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12032-023-02286-1","volume":"41","author":"A Salehi","year":"2024","unstructured":"Salehi A. A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia. Med Oncol. 2024;41:62.","journal-title":"Med Oncol"},{"key":"2453_CR30","doi-asserted-by":"publisher","first-page":"23073","DOI":"10.18632\/oncotarget.14981","volume":"8","author":"P Macanas-Pirard","year":"2017","unstructured":"Macanas-Pirard P, Broekhuizen R, Gonz\u00e1lez A, Oyanadel C, Ernst D, Garc\u00eda P, et al. Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome. Oncotarget. 2017;8:23073\u201386.","journal-title":"Oncotarget"},{"key":"2453_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-020-04170-5","volume":"87","author":"RI Mancuso","year":"2021","unstructured":"Mancuso RI, Foglio MA, Olalla Saad ST. Artemisinin-type drugs for the treatment of hematological malignancies. Cancer Chemother Pharmacol. 2021;87:1\u201322.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2453_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3892\/br.2022.1575","volume":"17","author":"HT Chi","year":"2022","unstructured":"Chi HT, Ly BTK. Artemisia vulgaris inhibits BCR\/ABL and promotes apoptosis in chronic myeloid leukemia cells. Biomed Rep. 2022;17:92.","journal-title":"Biomed Rep"},{"key":"2453_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.14715\/cmb\/2017.63.11.15","volume":"63","author":"R Metoui","year":"2017","unstructured":"Metoui R, Bouajila J, Znati M, Cazaux S, Neffati M, Akrout A. Bioactive flavones isolated from Tunisian Artemisia campestris L. Leaves Cell Mol Biol. 2017;63:86\u201391.","journal-title":"Leaves Cell Mol Biol"},{"key":"2453_CR34","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","volume":"11","author":"A van Rhenen","year":"2005","unstructured":"van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res. 2005;11:6520\u20137.","journal-title":"Clin Cancer Res"},{"key":"2453_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cancers13030376","volume":"13","author":"M Marzagalli","year":"2021","unstructured":"Marzagalli M, Fontana F, Raimondi M, Limonta P. Cancer stem cells\u2014key players in tumor relapse. Cancers. 2021;13:376.","journal-title":"Cancers"},{"key":"2453_CR36","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/cells8090957","volume":"8","author":"M Nedeljkovi\u0107","year":"2019","unstructured":"Nedeljkovi\u0107 M, Damjanovi\u0107 A. Mechanisms of chemotherapy resistance in triple-negative breast cancer\u2014how we can rise to the challenge. Cells. 2019;8:957.","journal-title":"Cells"},{"key":"2453_CR37","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","volume":"14","author":"CT Jordan","year":"2000","unstructured":"Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 2000;14:1777\u201384.","journal-title":"Leukemia"},{"key":"2453_CR38","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","volume":"105","author":"ML Guzman","year":"2005","unstructured":"Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 2005;105:4163\u20139.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02453-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T10:17:09Z","timestamp":1722593829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02453-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2453"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02453-y","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments using human cells were exempted by the Institutional Review Board of Pasteur Institute (IRB Number: 2021\/09\/E).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"206"}}